Prudential PLC Catalent, Inc. Transaction History

Prudential PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $1,609 - $2,328	-50 Reduced 0.53%	9,460 $425,000
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $1,083 - $2,286	-34 Reduced 0.36%	9,510 $412,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $136 - $222	3 Added 0.03%	9,544 $627,000
Q4 2022 Feb 08, 2023	BUY	$41.39 - $81.0 $259,515 - $507,870	6,270 Added 191.68%	9,541 $429,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $21,708 - $33,930	300 Added 10.1%	3,271 $237,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $24,939 - $32,618	-286 Reduced 8.78%	2,971 $319,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $306,776 - $405,463	3,257 New	3,257 $361,000
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $1.6 Million - $1.84 Million	-15,935 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $929,121 - $1.15 Million	-9,153 Reduced 36.48%	15,935 $1.68 Million
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $103,485 - $126,958	-1,205 Reduced 4.58%	25,088 $2.61 Million
Q3 2020 Oct 30, 2020	SELL	$72.74 - $92.5 $183,741 - $233,655	-2,526 Reduced 8.77%	26,293 $2.25 Million
Q2 2020 Jul 31, 2020	BUY	$48.02 - $79.04 $1.38 Million - $2.28 Million	28,819 New	28,819 $2.11 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.